Barahona et al. [9] showed that diagnosing GDM early in pregnancy is a predictor of adverse maternal and neonatal outcomes, such as pregnancy-induced hypertension, insulin treatment during pregnancy, preterm birth, hyperbilirubinemia and perinatal mortality. This evidence concerns the gene INS and gestational diabetes.